Rossignol, J., Ouedrani, A., Bulai-Livideanu, C., Barete, S., Terriou, L., Launay, D., . . . Hermine, O. (2021, September). Absence of severe COVID-19 in patients with clonal mast cells activation disorders: Effective anti-SARS-CoV-2 immune response bioRxiv. https://doi.org/10.1101/2021.09.01.458516
Chicago Style (17th ed.) CitationRossignol, Julien, et al. "Absence of Severe COVID-19 in Patients with Clonal Mast Cells Activation Disorders: Effective Anti-SARS-CoV-2 Immune Response." BioRxiv Sep. 2021. https://doi.org/10.1101/2021.09.01.458516.
MLA (9th ed.) CitationRossignol, Julien, et al. "Absence of Severe COVID-19 in Patients with Clonal Mast Cells Activation Disorders: Effective Anti-SARS-CoV-2 Immune Response." BioRxiv, Sep. 2021, https://doi.org/10.1101/2021.09.01.458516.